Journal of Allergy and Clinical Immunology

Impact factor
9.773 (2008)

Some content from Wikipedia, licensed under CC BY-SA


New study points to a better way to ward off asthma triggers

Every day, ten Americans die from asthma. While quick-acting inhalers and medications can reduce inflammation during an asthma attack, people with asthma have few tools to prevent the next attack from coming.

Diseases, Conditions, Syndromes

Most psoriasis patients taking immunosuppressants survive COVID-19

Patients with psoriasis who are taking drugs that affect their immune system have high rates of survival from COVID-19. According to the first findings from a global registry of psoriasis and COVID-19 patients, led by Guy's ...

Diseases, Conditions, Syndromes

COVID-19 outcomes in patients with rare inborn immune disorders

A new research report reveals that 94 individuals with rare inherited immune disorders, otherwise known as primary immunodeficiency (PID), who were infected with the SARS-CoV-2 coronavirus had similar disease outcomes to ...


Research helps pave way for newly approved use of drug

Following two decades of research on a group of rare diseases called hypereosinophilic syndrome at Cincinnati Children's Hospital Medical Center, the U.S. Food and Drug Administration has approved the drug Nucala (mepolizumab) ...


Researchers identify master regulator genes of asthma

Researchers identify master regulator genes of asthma, provide new path forward in the study of asthma and the development of novel therapies. Identification of these master regulator genes provides a new path forward in ...

page 1 from 29